INTRODUCTION
Streptococcus agalactiae,κ orκ Lanceieldκ groupκ BκStreptococcusκ(GBS),κisκoneκofκtheκmostκim− portantκcausalκagentκofκseriousκinfectionsκandκ neonatalκsepsis.
1−3 κAsκmanyκasκ40%κofκallκpreg− nantκwomenκpresentκrectalκand/orκvaginalκGBSκ κ colonization. 4 κ Theκ incidenceκ ofκ neonatalκ κ GBSκinfectionκisκ0.5κperκ100κliveκbirths.κVerti− calκtransmissionκfromκmotherκtoκtheκneonateκ byκeitherκpathwayκaccountsκforκupκtoκ75%κofκ casesκ ofκ neonatalκ GBSκ colonization,κ andκ 1%κ toκ2%κofκtheseκinfantsκwillκdevelopκearly−onsetκ GBSκinfection. 5, 6 Sinceκ 2002,κ theκ Centersκ forκ Diseaseκ Con− trolκ andκ Preventionκ (CDC)κ recommendκ GBSκ screeningκ forκ pregnantκ womenκ byκ culture− basedκ method.κ hisκ approachκ isκ preferable,κ resultingκ inκ moreκ efectiveκ preventionκ thatκ risk−basedκ chemoprophylaxisκ (previousκ CDCκ recommendation). 7−9 κ Theκ standardκ methodκ forκtheκdiagnosisκofκGBSκcolonizationκconsistsκ ofκ culturingκ combinedκ vaginalκ andκ analκ swabκ inκ aκ selectiveκ brothκ mediumκ thatκ inhibitsκ theκ growthκ ofκ non−GBSκ microorganisms.κ Howev− er,κ thisκ methodκ requiresκ atκ leastκ 48hκ forκ fullyκ GBSκidentiication.κMoreover,κnegativeκcultureκ κ resultsκ areκ observedκ inκ someκ womenκ whoseκ κ infantsκsubsequentlyκdevelopκGBSκinfection. 10 κ Anκ idealκ screeningκ testκ forκ GBSκ coloniza− tionκ isκ whichκ couldκ accuratelyκ identifyκ preg− nantκ womenκ whoκ carryκ theκ bacteriaκ (evenκ low−countκ bacteriaκ carriers)κ andκ presentingκ aκ shortκturnaroundκtime.κManyκtechniquesκhaveκ beenκ testedκ inκ orderκ toκ validateκ aκ fastκ andκ ef− icientκ methodκ ofκ GBSκ screeningκ toκ replaceκ theκ culture.
11−13 κ Nowadays,κ molecularκ biologyκ basedκ assays,κ suchκ asκ PCRκ (polymeraseκ chainκ reaction)κ tests,κ haveκ becomeκ theκ focusκ ofκ in− vestigationκ ofκ detectionκ ofκ GBSκ colonizationκ inκpregnantκwomen. 14, 15 κInκtheseκtests,κsamplesκ preparationκ andκ ampliicationκ targetsκ areκ de− cisiveκtoκperformanceκassay.κAκgoodκtargetκforκ GBSκampliicationκisκtheκatrκgeneκbecauseκitκisκ wellκ studiedκ inκ thisκ species.κ Moreover,κ theκ atrκ isκanκessentialκgene,κwhichκmeansκthatκitκhasκtoκ beκexpressed/presentκinκallκcellsκofκthisκspecies.κ heκgeneκencodesκaκproteinκaminoκacidκtrans− porterκ gs0538κ whichκ isκ extremelyκ speciicκ toκ κ S. agalactiaeκspecies.κBecauseκitκisκaκhousekeepingκ gene,κprobabilityκofκmutationsκinκatrκisκcompar− ativelyκratherκlow.
16,17
Este é um artigo Open Access sob a licença de CC BY-NC-ND heκ aimκ ofκ studyκ wasκ compareκ thisκ atrκ geneκ PCRκ withκ theκ goldκ standardκ (culture−basedκ method)κ toκ evaluateκ theκ PCRκperformanceκasκGBSκcolonizationκscreeningκinκpreg− nantκwomen.κAdditionally,κweκtestedκtwoκdiferentκextrac− tionκ methodsκ toκ amplifyκ atrκ gene:κ aκ commercialκ kitκ andκ thermalκ lysisκ protocol,κ searchingκ moreκ cost−efectiveκ mo− lecularκtests.
MATERIALS AND METHODS

Samples
Combinedκrectal/vaginalκspecimensκwereκcollectedκtoκcon− ductκthisκstudyκaccordingκtoκtheκCDCκrecommendations. 
Microbiology tests
heκ swabsκ wereκ inoculatedκ intoκ Toddκ Hewittκ (Himediaκ Laboratories,κ India)κ selectiveκ mediumκ supplementedκ withκ gentamicinκ(8κμg/mL)κandκnalidixicκacidκ(15κμg/mL).κheκ selectiveκmediumκwasκincubatedκatκ36°Cκinκ5%κCO 2 κforκ18h,κ andκthenκsubculturedκontoκbloodκagarκplatesκ(BioMérieux,κ Marcyκ l`Étoile,κ France),κ whichκ wereκ incubatedκ atκ 36°Cκ inκ 5%κCO 2 κforκ24h.κAterκincubationκtheκplatesκwereκinspectedκ forκ β−hemolyticκ colonies.κ Whenκ noκ β−hemolyticκ coloniesκ wereκ observedκ aterκ 24h,κ platesκ wereκ reincubatedκ forκ an− otherκ 24hκ andκ inspectedκ again.κ heκ β−hemolyticκ coloniesκ whoseκmorphologyκwasκconsistentκwithκgroupκBκStreptococ-cusκwereκsubculturedκinκbrothκandκsubmittedκtoκtheκCAMPκ (Christie,κAtkins,κMunch,κPetersen)κtest.κheκcoloniesκposi− tiveκforκtheκCAMPκtestκwereκpresumptivelyκconsideredκGBS.
Polymerase chain reaction (PCR)
Sample preparation and DNA extraction heκswabsκwereκincubatedκforκ15κtoκ18hκintoκToddκHewittκ selectiveκmedium.κAterκcentrifugationκofκbroth,κtheκprecip− itateκwasκwashedκwithκ1XκPBSκsolutionκandκresuspendedκinκ TEκbuferκ(10κmMκTris−HCl,κ0.1κmMκEDTA,κpHκ7.5).κhisκ solutionκ wasκ submittedκ toκ twoκ diferentκ DNAκ extractionκ protocols:κthermalκlysisκandκthermalκlysisκfollowedκbyκsilicaκ DNAκextractionκbyκcommercialκkit.κ heκthermalκlysisκwasκperformedκusingκTEκsolutionκforκ 10κ minκ atκ 100°Cκ toκ lyseκ bacterialκ cellκ wall. 18 κ heκ secondκ DNAκ extractionκ protocolκ wasκ performedκ usingκ theκ com− mercialκkitκQIAmpκ(Qiagen,κValencia,κUSA),κaccordingκtoκ manufacturersκ instructions.κ hisκ additionalκ stepκ inκ DNAκ extractionκwasκconductedκforκensuringκtheκPCRκinhibitorsκ elimination.κ
Polymerase chain reaction (PCR) gene atr
Forκ theκ PCRκ reactionκ weκ usedκ theκ atrκ primersκ 5'− CAAκ CGAκ TTCκ TCTκ CAGκ CTTκ TGTκ TAA−3'κ andκ κ 5'−TAAκ GAAκ ATCκ TCTκ TGTκ GCGκ GATκ TTC−3' ,κ κ producingκ aκ 780−bpκ fragmentκ thatκ isκ specificκ forκ theκ geneκ atr. 19 κ Theκ amplifiedκ PCRκ productκ ofκ oneκ clinicalκ isolateκwasκsequencedκandκtheκatrκsequenceκobtainedκwasκ comparedκinκGenBankκusingκtheκBasicκLocalκAlignmentκ SearchκToolκ(BLAST)κofκNationalκCenterκforκBiotechnol− ogyκ Information,κ Bethesda,κ MDκ (http://www.ncbi.nlm. nih.gov/BLAST/).κThisκisolateκsampleκwasκusedκasκaκpos− itiveκcontrolκinκallκPCRκreactions.
Theκ volumeκ ofκ reactionκ wasκ 25κ μLκ andκ wasκ pre− paredκasκfollows:κ67κmMκTris−HCl,κ16κmMκ(NH4) 2 
Theκamplificationκproductsκwereκdetectedκbyκelectro− phoresisκusingκ10κμLκofκtheκamplifiedκreactionκmixtureκ inκagaroseκgelκ2%,κcontainingκ0.4κmg/mLκethidiumκbro− mide.κVisualizationκwasκperformedκwithκultravioletκlightκ transilluminator.κ Aκ 100−bpκ molecularκ weightκ markerκ (Invitrogen ® ,κ Calbad,κ USA)κ andκ aκ positiveκ controlκ ofκ κ S. agalactiaeκ wereκ usedκ toκ evaluateκ theκ PCRκ products.κ Theκsamplesκpresentingκaκ780−bpκampliconκwereκconsid− eredκpositiveκforκGBS.κ
Statistical analysis
Sensitivity,κ specificity,κ PPVκ andκ NPVκ wereκ calculatedκ forκ theκ PCRκ techniqueκ usingκ cultureκ asκ goldκ standard. Theκconcordanceκbetweenκassaysκwasκdeterminedκusingκ theκ Kappaκ coefficient.κ Theκ statisticalκ analysisκ wasκ per− formedκinκSPSS ® κversionκ14.0. 
RESULTS
Inκ
DISCUSSION
Despiteκ CDCκ recommendationsκ toκ useκ cultureκ asκ GBSκ screeningκinκpregnantκwomen,κmanyκroutineκclinicalκsitu− ationsκ requireκ aκ fasterκ andκ moreκ eicientκ methodκ thanκ culture.
11−13 κ herefore,κ thisκ studyκ reportsκ resultsκ forκ twoκ diferentκ extractionκ protocolsκ andκ theκ useκ ofκ atrκ geneκ asκ ampliicationκ targetκ byκ PCRκ andκ itsκ potentialκ useκ asκ GBSκ screeningκ test.κ hermalκ lysisκ isκ theκ cheapestκ extractionκ methodκandκhasκgoodκperformanceκforκthisκsamplesκwhenκ comparedκtoκtheκQiagenκkit.κhisκextractionκprotocolκcouldκ presentκ theκ bestκ cost−efectivenessκ ratioκ whenκ appliedκ inκ clinicalκlaboratoryκroutine.
GBSκ colonizationκ ratesκ wereκ 15.96%κ usingκ theκ cul− tureκandκ26.99%κusingκPCR.κInκBrazil,κtheκGBSκcoloniza− tionκ rateκ wasκ estimatedκ byκ Borgerκ andκ co−workersκ toκ beκ betweenκ 15%κ toκ 25%.κ However,κ theκ prevalenceκ ofκ GBSκ colonizationκ couldκ varyκ widelyκ withκ geographicκ location,κ age,κ parityκ andκ socio−economicκ status. 21 κ Furthermore,κ aκ κ reviewκconductedκinκ1998κonκtheκprevalenceκofκcoloniza− tionκbyκGBSκinκdevelopingκcountriesκsuggestedκthatκcoloni− zationκratesκmayκbeκunderestimatedκinκmanyκstudiesκdueκtoκ κ inadequateκ cultureκ techniquesκ employed. 22 κ Recentκ Brazil− ianκstudiesκusingκPCRκtoκdetectκGBSκhaveκreportedκ21.6%κ 23 ,κwhereκtheκsensitivityκwasκ95.8%κandκ90.5%,κre− spectively.κProbably,κtheκhighκsensibilityκisκdueκtoκuseκofκse− lectiveκandκenrichedκbrothκpreviousκtoκperformingκtheκPCR.κ heκnegativeκpredictiveκvalueκwasκ100%.κhisκindingκisκim− portantκ becauseκ itκ indicatesκ thatκ allκ samplesκ withκ negativeκ resultsκ areκ trulyκ negative,κ whichκ afordsκ toκ safelyκ withholdκ treatmentκ fromκ womenκ presentingκ PCRκ negativeκ samples.κ hisκisκsoκimportantκinκclinicalκroutineκbecauseκfalseκnegativeκ resultsκinκaκscreeningκtestκmayκleadκtoκseriousκconsequencesκ forκ theκ patient,κ consideringκ thatκ thisκ testκ isκ usedκ toκ takeκ aκ decisionκaboutκantibioticκprophylaxis.
PCR
heκspeciicityκfoundκwasκ86.88%,κgreaterκthanκtheκ64.5%κ foundκbyκGavinoκ&κWang. 15 κHowever,κevenκbeingκconsideredκ theκgoldκstandard,κcultureκresultsκcanκbeκfalseκnegative.κItκisκ knownκ thatκ cultureκ mayκ notκ beκ absolutelyκ efectiveκ inκ theκ detectionκofκGBS,κsinceκotherκbacteriaκofκtheκvaginal/genitalκ tractκcanκinhibitκtheκgrowthκofκGBSκevenκwhenκusingκtheκse− lectiveκbroth.κSo,κtheκsupposedlyκfalseκpositiveκresultsκinκPCRκ mayκactuallyκindicateκtheκpresenceκofκGBSκinκtheκstudiedκma− terial,κsinceκthisκisκanκanalyticalκtechniqueκwhoseκsensitivityκ couldκbeκgreaterκthanκtheκbacteriologicalκexamination.κheκ goldκ standardκ performanceκ afectsκ theκ positiveκ predictiveκ valueκ parameter.κ Consequently,κ inκ ourκ studyκ theκ positiveκ predictiveκvalueκwasκ59%.κ Moreover,κtheκcultureκisκaκtime−consumingκmethodκrequir− ingκatκleastκ48hκforκfullyκGBSκidentiication.κheκPCRκproposedκ inκ thisκ study,κ evenκ usingκ aκ previousκ incubationκ inκ selectiveκ broth,κrequiresκ24hκtoκgiveκtheκinalκresult.κherefore,κGBSκPCRκ hasκaκconsiderableκshorterκturnaroundκtimeκthanκtheκculture.
Inκ summary,κ sinceκ theκ publicationκ ofκ theκ Guidelinesκ ofκGBSκcolonizationκbyκtheκCDCκinκ2002,κtheκincidenceκofκ κ neonatalκinfectionsκdecreasedκbyκmoreκthanκ60%.κheκuseκofκ newκtechniquesκwithκhigherκaccuracyκandκfasterκresultsκforκ detectionκofκthisκmicroorganismκcouldκcontributeκevenκfur− therκtoκthisκimprovement. 2 κAccordingly,κourκstudyκindicatesκ thatκtheκPCRκtechniqueκhasκprovenκtoκhaveκhighκsensitivity,κ andκthatκitκshouldκbeκaκusefulκscreeningκmethod.κSuchκmeth− odologyκcanκbeκaκdiagnosticκtoolκforκGBS,κallowingκefectiveκ treatmentκandκdecreasingκnewbornκmorbidityκandκmortality.κ Inκ thisκ scenario,κ cost−efectivenessκ studiesκ areκ necessaryκ toκ assessκtheκfeasibilityκofκimplementingκthisκmethodκasκaκrou− tineκinκcentersκwithκmaternityκwards.
